care & love
Pediatric neurological conditions such as cerebral palsy (CP), spinal muscular atrophy (SMA), and acquired brain injuries often result in significant motor impairments that affect a child's ability to walk independently. For these children, achieving mobility is not just a physical milestone — it is a gateway to social participation, psychological well-being, and overall development. In recent years, gait-assist devices have emerged as transformative tools in pediatric neurorehabilitation programs, offering new hope for children and their families.
Cerebral palsy is the most common form of motor disability in childhood, affecting approximately 2 out of every 1,000 children in Europe and similarly across other regions. Around 70% of children with CP experience walking difficulties, ranging from mild gait abnormalities to complete inability to walk independently. Traditional rehabilitation approaches — including physical therapy, bracing, and conventional walkers — have long been the standard of care. However, these methods often fall short for children with severe motor impairments who lack the trunk control and upper extremity strength needed to use conventional walking aids.
This is where lower limb exoskeleton robot technology steps in. Unlike traditional walkers or stationary treadmill-based systems, modern gait-assist devices are designed to support the child's body weight, guide proper joint alignment, and facilitate a natural, reciprocating gait pattern — all while allowing the child to move freely in their environment.
Gait-assist devices used in pediatric settings can be broadly categorized into two types: stationary (treadmill-based) systems and overground (wearable) exoskeletons. Stationary systems like the Lokomat use a treadmill and body-weight support harness, while overground exoskeletons are worn directly by the child and allow free movement in real-world settings. Overground devices are increasingly preferred because they promote active engagement — a critical factor for successful pediatric rehabilitation — and enable training in natural environments, including at home.
A typical robot-assisted gait training session involves the child wearing a lightweight exoskeleton that provides powered assistance to the hip, knee, and ankle joints. Multi-sensor systems detect the child's movement intentions and adjust support accordingly, enabling an active-assistive mode where the child initiates movement and the device provides just enough help to complete it. This approach aligns with motor learning principles: by repeatedly practicing proper gait patterns, the nervous system can reorganize and strengthen the neural pathways responsible for walking.
A growing body of clinical research supports the use of gait-assist exoskeletons in pediatric populations. A systematic review of 21 clinical articles found that robot-assisted gait training (RAGT) with exoskeletons is safe for children with CP, though the authors noted that larger controlled trials are needed to confirm efficacy. More recent studies have shown promising results: children using overground exoskeletons demonstrated statistically significant improvements in gross motor function, walking speed, and range of motion compared to those receiving conventional therapy alone.
One study evaluating the use of a reciprocating gait exoskeleton in 22 children with severe CP found that the majority achieved measurable improvements in walking endurance and speed after 20 training sessions, with many reaching clinically meaningful velocity thresholds. Importantly, families reported high levels of satisfaction, noting that the device enhanced social interaction and allowed their children to participate more fully in daily activities. Caregivers using the ICF (International Classification of Functioning) framework highlighted improvements not only in body function but also in activity, participation, and environmental engagement.
The benefits of integrating gait-assist devices into pediatric neurorehabilitation programs extend beyond simple mobility. Research and clinical experience point to several key advantages:
Mona Care offers a comprehensive range of gait training robot solutions designed to meet the diverse needs of pediatric and adult patients. At the heart of the pediatric lineup is the Rabbit Kid, a children's lower limb exoskeleton robot specifically engineered for young patients with lower limb motor function disorders. Featuring safe and comfortable human-machine interaction design, the Rabbit Kid offers multiple training modes to enhance active motor skills. It has been successfully deployed in several respected institutions, including Hong Kong Christian Service's Pui Yi School, the Hong Kong Red Cross' Margaret Trench School, Haven of Hope Sunnyside School, and the Duchess of Kent Children's Hospital.
For patients requiring individualized gait rehabilitation, the Gait Assist exoskeleton provides advanced multi-sensor fusion technology that identifies movement intentions in real time. This allows for personalized parameter adjustment — a critical feature for pediatric patients whose needs evolve as they grow and develop. The system's high-power electric control delivers strong, consistent output, while the ability to export training data supports medical, educational, and research applications. Both the Rabbit Kid and Gait Assist are IEC 60601 certified, ensuring the highest standards of safety and reliability for vulnerable pediatric users.
For adult patients with lower limb motor dysfunction caused by stroke or neurological conditions, the Bear Adult exoskeleton delivers up to 50 Nm of continuous torque, biomechanical modeling that simulates natural human gait, and multiple functional training modes — all within a medical-grade platform suitable for rehabilitation departments, neurology units, and intensive care settings.
For optimal outcomes, gait-assist devices should be integrated into a broader, multidisciplinary rehabilitation program. Most clinical protocols recommend sessions two to three times per week, lasting 45 to 60 minutes each, over a period of 8 to 12 weeks. The device should be used in conjunction with conventional physical therapy, occupational therapy, and family-centered care. Clinicians should regularly assess progress using standardized tools such as the Gross Motor Function Measure (GMFM-88), the Modified Ashworth Scale for spasticity, and goniometric measurements of joint range of motion.
It is also important to consider the child's developmental stage and the concept of neuroplasticity. Early intervention — particularly during critical developmental windows in the first years of life — may yield the greatest benefits, as the young brain is most adaptable to motor learning experiences. Gait-assist devices that are adjustable to accommodate a child's growth, like the Rabbit Kid and Gait Assist from Mona Care, are especially valuable for long-term rehabilitation programs.
Gait-assist devices are playing an increasingly important role in pediatric neurological rehabilitation programs. By providing safe, repetitive, and task-specific training, these devices help children with conditions like cerebral palsy and spinal muscular atrophy develop the motor skills needed for independent walking. The clinical evidence, while still evolving, consistently points to improvements in gross motor function, joint mobility, muscle strength, and overall quality of life.
Mona Care's portfolio of gait-assist solutions — including the Rabbit Kid pediatric exoskeleton, the Gait Assist system, and the Bear Adult exoskeleton — offers healthcare providers and families access to certified, clinically tested technology that can be integrated into both hospital-based and home-based rehabilitation programs. As research continues to advance and technology becomes more accessible, gait-assist devices are poised to become a standard component of pediatric neurorehabilitation, helping more children take their first confident steps toward a more independent future.